MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2017 International Congress

    Patient Clustering through a Mobile-based PD Severity Score

    A. Zhan, S. Mohan, M. Elson, E. Dorsey, A. Terzis, S. Saria (Baltimore, MD, USA)

    Objective: To demonstrate that PD patients can be clustered based on their performance on smartphone-enabled active tests. Background: Treatment decisions of PD require granular information…
  • 2017 International Congress

    Co-speech gestures in Parkinson’s disease (PD)

    M. Bacigalupe (La Plata, Argentina)

    Objective: We develop an analytical description of co-speech gesture production in PD patients. Background: Communication and expressive behavior problems are frequent in PD patients (Duncan…
  • 2017 International Congress

    Semi-automated MRI algorithm using susceptibility weighted imaging for differentiating multiple system atrophy with parkinsonism from Parkinson Disease

    W.-W. Lee, H.-J. Kim, C.-H. Sohn, H. Park, B. Jeon (Seoul, Republic of Korea)

    Objective: To investigate the diagnostic value of semi-automated diagnostic algorithm using 3T-MR susceptibility-weighted image (SWI) for multiple system atrophy with parkinsonism (MSA-p). Background: Iron deposition…
  • 2017 International Congress

    High systolic blood pressure is associated with cognitive impairment in Parkinson’s disease (PD)

    H. Chan, Y. Cheung, T. Fung, A. Leung, W. Fong (Hong Kong, Hong Kong)

    Objective: To assess if metabolic risk factors are associated with cognitive dysfunction in PD patients. Background: Metabolic syndrome is known as a risk factor of many…
  • 2017 International Congress

    Depression and Cognitive Performance in Patients with Parkinson’s Disease

    A.J. Jacob, S. OJ, S. K, G. Kumarpillai (Bangalore, India)

    Objective: The aim of this study was to assess the relationship between  depression on cognitive performance in Parkinson’s disease  patients.  Background: There are very few…
  • 2017 International Congress

    Genetic analysis of RAB39B mutations in early-onset and familial Parkinson’s Disease in a Taiwanese population.

    C.-H. Lin, H.-H. Lin, R.-M. Wu, H.-I. Lin (Taipei, Taiwan)

    Objective: To examine the genetic contribution of RAB39B to early-onset and familial PD in a Taiwanese population. Background: Loss of function mutations in RAB39B were…
  • 2017 International Congress

    Kufor-Rakeb Syndrome due to a Novel ATP13A2 Mutation in two Chinese brothers

    E. Noch, N. Hellmers, C. Henchcliffe, H. Sarva (New York, NY, USA)

    Objective: To describe Kufor-Rakeb Syndrome (KRS) due to a novel ATP13A2 1459 C>T mutation in two Chinese siblings. Background: Kufor-Rakeb Syndrome is a rare autosomal…
  • 2017 International Congress

    Gait characteristics of freezing in patients with Parkinson’s disease

    S.-M. Cheon, S.-Y. Lee, J.W. Kim (Busna, Republic of Korea)

    Objective: To investigate gait characteristics of FOG, this study analyzed forward and backward gait of PD patients. Background: FOG is one of major risk factors…
  • 2017 International Congress

    The hardest symptoms that bother patients with Parkinson’s disease

    V. Vuletic (Rijeka, Croatia)

    Objective: In this study we want to see what are the hardest and the most troublesome symptoms perceived by patients with Parkinson’s disease (PD). Background:…
  • 2017 International Congress

    The Use of Atypical Antipsychotics in Depression and Anxiety may Unmask Parkinson’s Disease: A Retrospective Chart Review

    K. Amodeo, R. Schneider, I. Richard (Rochester, NY, USA)

    Objective: Characterize the population with parkinsonism and exposure to antipsychotics who underwent dopamine transporter single-photon emission computed tomography (DATSPECT). Background: Atypical antipsychotics are used in …
  • « Previous Page
  • 1
  • …
  • 318
  • 319
  • 320
  • 321
  • 322
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley